Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI) (fMRI)
|ClinicalTrials.gov Identifier: NCT01607710|
Recruitment Status : Completed
First Posted : May 30, 2012
Last Update Posted : September 5, 2014
|Condition or disease|
|Generalized Anxiety Disorder|
|Study Type :||Observational|
|Actual Enrollment :||55 participants|
|Observational Model:||Case Control|
|Official Title:||Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)|
|Study Start Date :||July 2012|
|Primary Completion Date :||June 2014|
|Study Completion Date :||June 2014|
Generalized Anxiety Disorder
The group of participants diagnosed with generalized anxiety disorder.
Nonclinical Control Group
The comparison group of participants with no psychiatric diagnoses.
- Brain activation while undergoing the fMRI [ Time Frame: Throughout the fMRI ]Main effects for each condition will be calculated to elucidate brain activations relevant to the tasks. Random effect 2 sample t-tests will assess group differences (i.e., GAD patients vs. healthy controls) to identify regions that demonstrate hyperactivation in patients.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01607710
|United States, Connecticut|
|Hartford, Connecticut, United States, 06105|
|Principal Investigator:||Gretchen J Diefenbach, Ph.D.||Hartford Hospital|